Alert icon
We're changing our privacy policy. This stuff matters.  Learn more  Dismiss

Asparaginase as a Treatment in ALL - An Interview with Stephen Hunger, MD.

Loading...

Sign in or sign up now!
Alert icon
Upgrade to the latest Flash Player for improved playback performance. Upgrade now or more info.
46 views
Loading...
Alert icon
Sign in or sign up now!
Alert icon

Uploaded by on Jan 27, 2012

At the American Society of Hematology (ASH) 2011, Stephen Hunger, MD, Section Chief, Center for Cancer and Blood Disorders, discusses an overview of ALL, treatment with asparaginase, and the recent US approval of Erwinase® (asparaginase Erwinia chrysanthemi) for the treatment of ALL and the benefits to patients.

Category:

Education

Tags:

License:

Standard YouTube License

  • likes, 0 dislikes

Link to this comment:

Share to:
see all

All Comments (0)

Sign In or Sign Up now to post a comment!
Loading...

Alert icon
0 / 00Unsaved Playlist Return to active list
    1. Your queue is empty. Add videos to your queue using this button:
      or sign in to load a different list.
    Loading...Loading...Saving...
    • Clear all videos from this list
    • Learn more